Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomea Fusion Inc (BMEA)

Biomea Fusion Inc (BMEA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biomea Fusion Inc 1599 Industrial Road San Carlos CA 94070 USA

www.biomeafusion.com Employees: 106 P: 650-980-9099

Sector:

Medical

Description:

Biomea Fusion Inc. is a clinical-stage diabetes and obesity medicines company focused on the development of its oral small molecules, icovamenib and BMF-650. Biomea Fusion Inc., formerly known as BLOMEA FUSION, is based in Redwood City, California.

Key Statistics

Overview:

Market Capitalization, $K 98,279
Enterprise Value, $K 39,999
Shares Outstanding, K 70,704
Float, K 57,680
% Float 81.58%
Short Interest, K 11,309
Short Float 16.00%
Days to Cover 10.24
Short Volume Ratio 0.43
% of Insider Shareholders 18.42%
% of Institutional Shareholders 96.72%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -138,430 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -16,410 K
EBIT, $ -101,870 K
EBITDA, $ -100,120 K

Growth:

1-Year Return -47.60%
3-Year Return -89.31%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 11/04/25
Next Earnings Date 03/30/26 [--]
Earnings Per Share ttm -2.39
EPS Growth vs. Prev Qtr 47.06%
EPS Growth vs. Prev Year 70.33%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BMEA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -310.15%
Return-on-Assets % -145.38%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.22
Book Value/Share 0.26
Interest Coverage -4.33
60-Month Beta -0.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar